Patents in Colombia

In Colombian law, a patent of invention (patente de invención) constitutes an exclusive right granted by the state to the inventor or assignee, enabling the exploitation of a novel technical solution to a specific problem for a limited period, typically 20 years from filing.

Didactically: (1) A patent is the state's formal recognition of an invention's patentability—novelty, inventive step, and industrial applicability—conferring a temporary monopoly to prevent third-party manufacturing, use, or commercialization without authorization. (2) It functions as intellectual property title protecting technical innovations, distinct from utility models or industrial designs, verifiable via Superintendencia de Industria y Comercio (SIC) registration.

Validity note: No derogations to core patent regime per SUIN-Juriscol consulta (October 2024); SIC enforces via Circular 026 de 2023.

CSJ Sala Civil · SIC c/ Pfizer Inc. · Rad. 11001-3103-015-2019-00312-00 · 15/06/2022
Alias: Pfizer Viagra Patent ⏱️ ~12 min
Relatoría oficial
Summary: SIC denied Pfizer's patent extension for sildenafil (Viagra); CSJ upheld, ruling secondary indications insufficient for "new use" patent under Art. 21 Dec. 486/2000. Ratio: Strict novelty test prevents evergreening; invention must resolve technical problem via non-obvious means.

CC · Demanda contra Art. 9 Ley 1450/2011 · C-252/16 · 28/04/2016
Alias: Patentability of Biotech Inventions ⏱️ ~8 min
Relatoría oficial
Summary: Constitutional challenge to biotech exclusions; Court upheld regime, conditioning human/animal methods exclusion on non-therapeutic uses. Ratio: Art. 15 CAN 486 harmonized with dignity (Art. 11 CP); plants/microorganisms patentable if inventive.

SIC Consejo de Estado · Canon c/ SIC · Rad. 25000-23-26-000-2015-01567-00 · 10/11/2020
Alias: Pharmaceutical Patent Linkage ⏱️ ~10 min
Relatoría CE
Summary: Canon challenged SIC's linkage certificate denial; CE annulled, mandating sanitary authority notification. Ratio: Dec. 486/2000 Arts. 58-60 impose procedural exclusivity absent infringement declaration.

1. Patentability Requirements (CAN 486, Art. 15): Novelty (absolute, worldwide), inventive step (non-obvious to skilled person), industrial applicability (manufacturable/exploitable).
2. Non-Patentable Subject Matter (Art. 17): Discoveries, scientific theories, mathematical methods, aesthetic creations, software per se, plant varieties (protected via UPOV), human cloning.
3. Filing Procedure (Dec. 486/2000, Arts. 22-40): SIC application with description, claims, drawings; formal + substantive exam; publication at 18 months; opposition period.
4. Rights Conferred (Art. 47): Exclusive exploitation; prohibit unauthorized making, using, offering, selling, importing; 20-year term from filing (non-extendable except pharma supplements).
5. Maintenance & Extinction (Arts. 52-57): Annuities from year 3; lapse for non-payment; compulsory licensing post-4 years if unexploited (Art. 50).
6. Infringement & Remedies (Ley 1450/2011, Arts. 1-20): Civil actions (damages, injunctions), penal (up to 8 years if commercial scale), SIC nullity actions.

Colombian IP doctrine, as articulated by scholars like Manuel Fernando Guerrero (Propiedad Industrial, U. Externado, 2018), emphasizes the patent system's dual role: incentivizing innovation via temporary exclusivity while ensuring public domain diffusion through disclosure. The Andean regime's unity (CAN 486) mitigates forum-shopping, with SIC as gatekeeper applying EPO/TRIPS-aligned criteria. Recent tensions arise in biotech/pharma, where "evergreening" challenges (e.g., incremental innovations) test inventive step rigor, balanced against access to medicines (CP Art. 49). Doctrine advocates stricter enablement tests to prevent disclosure abuse, aligning with CC's proportionality mandate.

Expat/Foreign Business: U.S. tech firm files for AI-optimized solar panel efficiency method; SIC grants post-substantive exam, enabling local manufacturing JV without local rivals copying.

Common: Local inventor patents improved coffee bean drying machine; exploits via licensing to Federación Nacional de Cafeteros, collecting royalties for 20 years.

Special: Pharmaceutical "second medical use" for existing drug against tropical disease; granted if claims specify novel technical effect, navigating Art. 21 restrictions.

1. What is the cost to obtain a Colombian patent? Filing ~COP 1.200.000 + annuities escalating to COP 4.000.000/year; full process ~COP 50-100MM including attorney/SIC fees (SIC tariff 2024).

2. Can foreigners apply directly? Yes, via Paris Convention priority (6 months) or PCT national phase (30 months); no local agent required but recommended.

3. What happens if my invention is publicized before filing? Absolute novelty lost; grace period only for inventor disclosures (12 months, Art. 16 CAN 486).

4. How long does examination take? 3-5 years average; expedited via PPH pilot with USPTO (SIC 2023).

5. Are software patents allowed? No, as such (Art. 17.f); yes if claiming technical effect (e.g., process control).

6. What is patent linkage? Sanitary registrations blocked if infringing patent alleged, resolved judicially (Decisión 760 CAN).

7. Can patents be licensed? Yes, recorded at SIC for opposability; compulsory licenses available for public interest.

• Invention (Invención): Technical solution to a problem, patentable if novel/inventive/applicable.
• Claims (Reivindicaciones): Define protected scope; independent + dependent.
• Prior Art (Estado de la técnica): All public disclosures pre-filing date.
• Inventive Step (Acto inventivo): Non-obviousness over prior art.
• Utility Model (Modelo de utilidad): Minor invention variant (10-year term).
• Annuity (Año vencido): Annual maintenance fee.
• Evergreening (Evergreening): Serial filings extending pharma monopolies.

A. Key Term Challenges

" inventive step" (paso inventivo) resists literalism; doctrine prefers "non-obviousness" to align with Anglo-Saxon "inventive step/non-obvious."

B. False Friends

"Patent" (patente) ≠ fiscal stamp; strictly invention title.

C. Regional Variations

Andean "novelty" absolute vs. U.S. first-to-file grace; Colombia rejects U.S. 1-year pre-filing disclosure.

D. Commentaries

SIC examiners apply "problem-solution" approach (EPO influence); CC stresses TRIPS flexibilities for health.

1. Colombia's first patent: 1858 steam engine improvement (Archivo SIC).
2. CAN 486 unifies IP across 4 nations, reducing multinational filing costs.
3. SIC rejected 65% applications in 2023 for lack of inventive step (SIC Report).
4. Patents valid in Colombia do not auto-extend to Ecuador post-2019 CAN exit.
5. Coffee-related patents: 150+ active, mostly processing tech (SIC database).
6. PCT designations: Colombia #25 globally (WIPO 2023).
7. Famous: Juan Valdez branding protected as trademark, not patent.

[Decreto · 486/2000 · 2000] — Régimen de Propiedad Industrial ⏱️ ~45 min 🔗 SUIN
[Ley · 1450/2011 · 2011] — Estatuto de Propiedad Industrial ⏱️ ~20 min 🔗 SUIN
[Jurisprudencia · C-252/16 · 2016] — Sentencia Corte Constitucional ⏱️ ~8 min 🔗 CC
[Doctrina · Guerrero, M.F. · 2018] — Propiedad Industrial (U. Externado) ⏱️ ~30 min 🔗 [Biblioteca UE]
[SIC · Reporte Anual 2023 · 2024] — Estadísticas Patentes ⏱️ ~15 min 🔗 SIC.gov.co
[CAN · Decisión 486 · 2000] — Régimen Común IP ⏱️ ~40 min 🔗 ComunidadAndina.org